Single-dose intravenous ketamine or intramuscular naltrexone for high-utilization inpatients with alcohol use disorder: pilot trial feasibility and readmission rates

HIGHLIGHTS

• who: Dale Terasaki from the Department of Behavioral Health, Denver Health and Hospital Association, Bannock St, Denver, CO, USA have published the research work: Single-dose intravenous ketamine or intramuscular naltrexone for high-utilization inpatients with alcohol use disorder: pilot trial feasibility and readmission rates, in the Journal: (JOURNAL) of 24/09/2020
• what: This pilot study demonstrated the feasibility of IV ketamine and verified the feasibility of IM naltrexone given pre-discharge in the medical hospital setting.
• future: Future investigation could explore methods to obtain these data utilizing substantial locator details obtained . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.